메뉴 건너뛰기




Volumn 16, Issue 15, 2015, Pages 2343-2354

Treatments options for alopecia

Author keywords

alopecia; alopecia areata; androgenetic alopecia; cicatricial alopecia; management; treatment

Indexed keywords

BIMATOPROST; CLOBETASOL PROPIONATE; CYPROTERONE ACETATE; DEXAMETHASONE; DITHRANOL; DUTASTERIDE; FINASTERIDE; FLUTAMIDE; LATANOPROST; METHYLPREDNISOLONE; MINOXIDIL; PREDNISOLONE; SPIRONOLACTONE; TRAVOPROST; TRIAMCINOLONE ACETONIDE;

EID: 84942196201     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2015.1084501     Document Type: Review
Times cited : (22)

References (97)
  • 1
    • 84861315357 scopus 로고    scopus 로고
    • Guidelines for the management of androgenetic alopecia
    • Tsuboi R, Itami S, Inui S, et al. Guidelines for the management of androgenetic alopecia. J Dermatol 2012;39(2):113-20
    • (2012) J Dermatol , vol.39 , Issue.2 , pp. 113-120
    • Tsuboi, R.1    Itami, S.2    Inui, S.3
  • 2
    • 0033811542 scopus 로고    scopus 로고
    • Androgenetic alopecia and microinflammation
    • Mahe'YF Michelet JF, Billoni N, et al. Androgenetic alopecia and microinflammation. Int J Dermatol 2000;39(8):576-84
    • (2000) Int J Dermatol , vol.39 , Issue.8 , pp. 576-584
    • Mahe'YF Michelet, J.F.1    Billoni, N.2
  • 3
    • 0345600190 scopus 로고    scopus 로고
    • Is androgenetic alopecia a photoaggravated dermatosis
    • Trueeb R. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology 2003;207(4):343-8
    • (2003) Dermatology , vol.207 , Issue.4 , pp. 343-348
    • Trueeb, R.1
  • 5
    • 77958162673 scopus 로고    scopus 로고
    • Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review
    • Mella JM, Perret MC, Manzotti M, et al. Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review. Arch Dermatol 2010;146(10):1141-50
    • (2010) Arch Dermatol , vol.146 , Issue.10 , pp. 1141-1150
    • Mella, J.M.1    Perret, M.C.2    Manzotti, M.3
  • 6
    • 0037357915 scopus 로고    scopus 로고
    • Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss
    • Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol 2003;13(2):150-60
    • (2003) Eur J Dermatol , vol.13 , Issue.2 , pp. 150-160
    • Whiting, D.A.1    Olsen, E.A.2    Savin, R.3
  • 7
    • 0042634152 scopus 로고    scopus 로고
    • The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
    • Tang L, Bernardo O, Bolduc C, et al. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad Dermatol 2003;49(2):229-33
    • (2003) J Am Acad Dermatol , vol.49 , Issue.2 , pp. 229-233
    • Tang, L.1    Bernardo, O.2    Bolduc, C.3
  • 8
    • 84919493544 scopus 로고    scopus 로고
    • Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: A serious concern or red herring
    • Singh MK, Avram M. Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: A serious concern or red herring? J Clin Aesthet Dermatol 2014;7(12):51-5
    • (2014) J Clin Aesthet Dermatol , vol.7 , Issue.12 , pp. 51-55
    • Singh, M.K.1    Avram, M.2
  • 9
    • 0032843781 scopus 로고    scopus 로고
    • Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men
    • Overstreet JW, Fuh VL, Gould J, et al. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 1999;162(4):1295-300
    • (1999) J Urol , vol.162 , Issue.4 , pp. 1295-1300
    • Overstreet, J.W.1    Fuh, V.L.2    Gould, J.3
  • 10
    • 84888420575 scopus 로고    scopus 로고
    • Finasteride use in the male infertility population: Effects on semen and hormone parameters
    • Samplaski MK, Lo K, Grober E, Jarvi K. Finasteride use in the male infertility population: effects on semen and hormone parameters. Fertil Steril 2013;100(6):1542-6
    • (2013) Fertil Steril , vol.100 , Issue.6 , pp. 1542-1546
    • Samplaski, M.K.1    Lo, K.2    Grober, E.3    Jarvi, K.4
  • 11
    • 79953315659 scopus 로고    scopus 로고
    • Finasteride induced gynecomastia: Case report and review of the literature
    • Ramot Y, Czarnowicki T, Zlotogorski A. Finasteride induced Gynecomastia: Case report and Review of the Literature. Int J Trichology 2009;1(1):27-9
    • (2009) Int J Trichology , vol.1 , Issue.1 , pp. 27-29
    • Ramot, Y.1    Czarnowicki, T.2    Zlotogorski, A.3
  • 12
    • 0037812658 scopus 로고    scopus 로고
    • The influence of finasteride on the development of prostate cancer
    • Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215-24
    • (2003) N Engl J Med , vol.349 , Issue.3 , pp. 215-224
    • Thompson, I.M.1    Goodman, P.J.2    Tangen, C.M.3
  • 13
    • 84931053296 scopus 로고    scopus 로고
    • Adverse event reporting in clinical trials of finasteride for androgenic alopecia: A meta-analysis
    • [Epub ahead of print]
    • Belknap SM, Aslam I, Kiguradze T, et al. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. JAMA Dermatol 2015. [Epub ahead of print]
    • (2015) JAMA Dermatol
    • Belknap, S.M.1    Aslam, I.2    Kiguradze, T.3
  • 14
    • 84912059201 scopus 로고    scopus 로고
    • A novel finasteride 0.25% topical solution for androgenetic alopecia: Pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
    • Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther 2014;52(10):842-9
    • (2014) Int J Clin Pharmacol Ther , vol.52 , Issue.10 , pp. 842-849
    • Caserini, M.1    Radicioni, M.2    Leuratti, C.3
  • 15
    • 0032722225 scopus 로고    scopus 로고
    • Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
    • Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41(5Pt1):717-21
    • (1999) J Am Acad Dermatol , vol.41 , Issue.5 , pp. 717-721
    • Price, V.H.1    Menefee, E.2    Strauss, P.C.3
  • 16
    • 0036737739 scopus 로고    scopus 로고
    • A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
    • Olsen EA, Dunlap F, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47(3):377-85
    • (2002) J Am Acad Dermatol , vol.47 , Issue.3 , pp. 377-385
    • Olsen, E.A.1    Dunlap, F.2    Funicella, T.3
  • 17
    • 35148886772 scopus 로고    scopus 로고
    • A multicenter, randomized, placebocontrolled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
    • Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebocontrolled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007;57(5):767-74
    • (2007) J Am Acad Dermatol , vol.57 , Issue.5 , pp. 767-774
    • Olsen, E.A.1    Whiting, D.2    Bergfeld, W.3
  • 18
    • 84920902013 scopus 로고    scopus 로고
    • Clinical utility and validity of minoxidil response testing in androgenetic alopecia
    • Goren A, Shapiro J, Roberts J, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 2015;28(1):13-16
    • (2015) Dermatol Ther , vol.28 , Issue.1 , pp. 13-16
    • Goren, A.1    Shapiro, J.2    Roberts, J.3
  • 19
    • 0031030541 scopus 로고    scopus 로고
    • Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growthstimulating effect
    • Michelet JF, Commo S, Billoni N, et al. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growthstimulating effect. J Invest Dermatol 1997;108:205-9
    • (1997) J Invest Dermatol , vol.108 , pp. 205-209
    • Michelet, J.F.1    Commo, S.2    Billoni, N.3
  • 20
    • 0141596174 scopus 로고    scopus 로고
    • Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal
    • Tosti A, Iorizzo M, Vincenzi C. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Arch Dermatol 2003;139(9):1221-2
    • (2003) Arch Dermatol , vol.139 , Issue.9 , pp. 1221-1222
    • Tosti, A.1    Iorizzo, M.2    Vincenzi, C.3
  • 21
    • 0036160607 scopus 로고    scopus 로고
    • Allergic contact dermatitis to topical minoxidil solution: Etiology and treatment
    • Friedman ES, Friedman PS, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 2002;46(2):309-12
    • (2002) J Am Acad Dermatol , vol.46 , Issue.2 , pp. 309-312
    • Friedman, E.S.1    Friedman, P.S.2    Cohen, D.E.3    Washenik, K.4
  • 22
    • 51349156637 scopus 로고    scopus 로고
    • Medical treatments for male and female pattern hair loss
    • Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 2008;59(4):547-66
    • (2008) J Am Acad Dermatol , vol.59 , Issue.4 , pp. 547-566
    • Rogers, N.E.1    Avram, M.R.2
  • 23
    • 33750830522 scopus 로고    scopus 로고
    • The importance of dual 5alphareductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
    • Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alphareductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006;55(6):1014-23
    • (2006) J Am Acad Dermatol , vol.55 , Issue.6 , pp. 1014-1023
    • Olsen, E.A.1    Hordinsky, M.2    Whiting, D.3
  • 24
    • 77955292679 scopus 로고    scopus 로고
    • Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebocontrolled, phase III study
    • Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebocontrolled, phase III study. J Am Acad Dermatol 2010;63(2):252-8
    • (2010) J Am Acad Dermatol , vol.63 , Issue.2 , pp. 252-258
    • Eun, H.C.1    Kwon, O.S.2    Yeon, J.H.3
  • 25
    • 84894075744 scopus 로고    scopus 로고
    • A randomized, active-and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
    • Gubelin Harcha W, Barboza Martnez J, Tsai TF, et al. A randomized, active-and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 2014;70(3):489-98
    • (2014) J Am Acad Dermatol , vol.70 , Issue.3 , pp. 489-498
    • Gubelin Harcha, W.1    Barboza Martnez, J.2    Tsai, T.F.3
  • 26
    • 84873408493 scopus 로고    scopus 로고
    • Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia
    • Boyapati A, Sinclair R. Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia. Australas J Dermatol 2013;54(1):49-51
    • (2013) Australas J Dermatol , vol.54 , Issue.1 , pp. 49-51
    • Boyapati, A.1    Sinclair, R.2
  • 27
    • 84890319168 scopus 로고    scopus 로고
    • The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: A network metaanalysis and benefit-risk assessment of finasteride and dutasteride
    • Gupta AK, Charrette A. The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: A network metaanalysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat 2014;25(2):156-61
    • (2014) J Dermatolog Treat , vol.25 , Issue.2 , pp. 156-161
    • Gupta, A.K.1    Charrette, A.2
  • 28
    • 84869180482 scopus 로고    scopus 로고
    • Hair transplantation update: Procedural techniques, innovations and applications
    • Bunagan MJK, Banka N, Shapiro J. Hair transplantation update: procedural techniques, innovations and applications. Dermatol Clin 2013;31:141-53
    • (2013) Dermatol Clin , vol.31 , pp. 141-153
    • Bunagan, M.J.K.1    Banka, N.2    Shapiro, J.3
  • 29
    • 33750238651 scopus 로고    scopus 로고
    • The role of platelet plasma growth factors in male pattern baldness surgery
    • Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006;118(6):1458-66
    • (2006) Plast Reconstr Surg , vol.118 , Issue.6 , pp. 1458-1466
    • Uebel, C.O.1    Da Silva, J.B.2    Cantarelli, D.3    Martins, P.4
  • 30
    • 84929516162 scopus 로고    scopus 로고
    • Promising alternative clinical uses of prostaglandin F2a analogs: Beyond the eyelashes
    • Choi YM, Diehl JM, Levins PC. Promising alternative clinical uses of prostaglandin F2a analogs: Beyond the eyelashes. J Am Acad Dermatol 2015;4:712-16
    • (2015) J Am Acad Dermatol , vol.4 , pp. 712-716
    • Choi, Y.M.1    Diehl, J.M.2    Levins, P.C.3
  • 31
    • 84859849330 scopus 로고    scopus 로고
    • A randomized double-blind placebocontrolled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
    • Blume-Peytavi U, Lonnfors S, Hillmann K, Garcia Bartels N. A randomized double-blind placebocontrolled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol 2012;66(5):794-800
    • (2012) J Am Acad Dermatol , vol.66 , Issue.5 , pp. 794-800
    • Blume-Peytavi, U.1    Lonnfors, S.2    Hillmann, K.3    Garcia Bartels, N.4
  • 32
    • 84873437891 scopus 로고    scopus 로고
    • The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
    • Khidhir KG, Woodward DF, Farjo NP, et al. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J 2013;27(2):557-67
    • (2013) FASEB J , vol.27 , Issue.2 , pp. 557-567
    • Khidhir, K.G.1    Woodward, D.F.2    Farjo, N.P.3
  • 34
    • 84881381686 scopus 로고    scopus 로고
    • Low-level light therapy for androgenetic alopecia: A 24-week, randomized, doubleblind, sham device-controlled multicenter trial
    • Kim H, Choi JW, Kim JY, et al. Low-level light therapy for androgenetic alopecia: A 24-week, randomized, doubleblind, sham device-controlled multicenter trial. Dermatol Surg 2013;39(8):1177-83
    • (2013) Dermatol Surg , vol.39 , Issue.8 , pp. 1177-1183
    • Kim, H.1    Choi, J.W.2    Kim, J.Y.3
  • 35
    • 84899701624 scopus 로고    scopus 로고
    • Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham devicecontrolled, double-blind study
    • Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham devicecontrolled, double-blind study. Am J Clin Dermatol 2014;15(2):115-27
    • (2014) Am J Clin Dermatol , vol.15 , Issue.2 , pp. 115-127
    • Jimenez, J.J.1    Wikramanayake, T.C.2    Bergfeld, W.3
  • 36
    • 67849099583 scopus 로고    scopus 로고
    • The use of low-level light for hair growth: Part i
    • Avram MR, Rogers NE. The use of low-level light for hair growth: part I. J Cosmet Laser Ther 2009;11(2):110-17
    • (2009) J Cosmet Laser Ther , vol.11 , Issue.2 , pp. 110-117
    • Avram, M.R.1    Rogers, N.E.2
  • 37
    • 84894270456 scopus 로고    scopus 로고
    • Low-level laser (light) therapy for treatment of hair loss
    • Avci P, Gupta GK, Clark J, et al. Low-level laser (light) therapy for treatment of hair loss. Laser Surg Med 2014;46(2):144-51
    • (2014) Laser Surg Med , vol.46 , Issue.2 , pp. 144-151
    • Avci, P.1    Gupta, G.K.2    Clark, J.3
  • 38
    • 84923262011 scopus 로고    scopus 로고
    • Platelet-rich plasma in androgenic alopecia: Myth or an effective tool
    • Khatu SS, More YE, Gokhale NR, et al. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg 2014;7(2):107-10
    • (2014) J Cutan Aesthet Surg , vol.7 , Issue.2 , pp. 107-110
    • Khatu, S.S.1    More, Y.E.2    Gokhale, N.R.3
  • 39
    • 84942193466 scopus 로고    scopus 로고
    • Autologous PRP injections in androgenic alopecia
    • Amgar G, Bouhanna P. Autologous PRP injections in androgenic alopecia. Prime 2015;5(2):24-34
    • (2015) Prime , vol.5 , Issue.2 , pp. 24-34
    • Amgar, G.1    Bouhanna, P.2
  • 40
    • 84868207008 scopus 로고    scopus 로고
    • Evidence-based treatments for female pattern hair loss: A summary of a Cochrane systematic review
    • Van Zuuren EJ, Fedorowicz Z, Carter B. Evidence-based treatments for female pattern hair loss: A summary of a Cochrane systematic review. Br J Dermatol 2012;167(5):995-1010
    • (2012) Br J Dermatol , vol.167 , Issue.5 , pp. 995-1010
    • Van Zuuren, E.J.1    Fedorowicz, Z.2    Carter, B.3
  • 41
    • 84883429643 scopus 로고    scopus 로고
    • Female pattern alopecia: Current perspectives
    • Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Women Health 2013;29(5):541-56
    • (2013) Int J Women Health , vol.29 , Issue.5 , pp. 541-556
    • Levy, L.L.1    Emer, J.J.2
  • 42
    • 81155150327 scopus 로고    scopus 로고
    • A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
    • Blume-Peytavi U, Hillmann K, Dietz E, et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011;65(6):1126-34
    • (2011) J Am Acad Dermatol , vol.65 , Issue.6 , pp. 1126-1134
    • Blume-Peytavi, U.1    Hillmann, K.2    Dietz, E.3
  • 43
    • 33845990900 scopus 로고    scopus 로고
    • Antiandrogen therapy for androgenetic alopecia
    • Yip L, Sinclair R. Antiandrogen therapy for androgenetic alopecia. Expert Rev Dermatol 2006;1(2):261-9
    • (2006) Expert Rev Dermatol , vol.1 , Issue.2 , pp. 261-269
    • Yip, L.1    Sinclair, R.2
  • 44
    • 0036067176 scopus 로고    scopus 로고
    • Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial
    • Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial. Br J Dermatol 2002;146(6):992-9
    • (2002) Br J Dermatol , vol.146 , Issue.6 , pp. 992-999
    • Vexiau, P.1    Chaspoux, C.2    Boudou, P.3
  • 45
    • 0037227510 scopus 로고    scopus 로고
    • Treatment of hyperandrogenic alopecia in women
    • Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril 2003;79(1):91-5
    • (2003) Fertil Steril , vol.79 , Issue.1 , pp. 91-95
    • Carmina, E.1    Lobo, R.A.2
  • 46
    • 79955631133 scopus 로고    scopus 로고
    • Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss
    • Paradisi R, Porcu E, Fabbri R, et al. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother 2001;45(4):469-75
    • (2001) Ann Pharmacother , vol.45 , Issue.4 , pp. 469-475
    • Paradisi, R.1    Porcu, E.2    Fabbri, R.3
  • 47
    • 0033752238 scopus 로고    scopus 로고
    • Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
    • Price VH, Roberts Jl, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000;43(5Pt1):768-76
    • (2000) J Am Acad Dermatol , vol.43 , Issue.5 , pp. 768-776
    • Price, V.H.1    Roberts, J.L.2    Hordinsky, M.3
  • 48
    • 33645110044 scopus 로고    scopus 로고
    • Finasteride treatment in female pattern hair loss
    • Iorizzo M, Vincenzi C, Voudouris S, et al. Finasteride treatment in female pattern hair loss. Arch Dermatol 2006;142(3):298-302
    • (2006) Arch Dermatol , vol.142 , Issue.3 , pp. 298-302
    • Iorizzo, M.1    Vincenzi, C.2    Voudouris, S.3
  • 49
    • 27144458443 scopus 로고    scopus 로고
    • Effective treatment of female androgenic alopecia with dutasteride
    • Olszewska M, Rudnika L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol 2005;4(5):637-40
    • (2005) J Drugs Dermatol , vol.4 , Issue.5 , pp. 637-640
    • Olszewska, M.1    Rudnika, L.2
  • 50
    • 84973412366 scopus 로고    scopus 로고
    • The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
    • Boersma IH, Oranje AP, Grimalt R, et al. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol 2014;80(6):521-5
    • (2014) Indian J Dermatol Venereol Leprol , vol.80 , Issue.6 , pp. 521-525
    • Boersma, I.H.1    Oranje, A.P.2    Grimalt, R.3
  • 51
    • 77954879970 scopus 로고    scopus 로고
    • Androgenetic alopecia in the paediatric population: A retrospective review of 57 patients
    • Gonzalez ME, Cantatore-Francis J, Orlow SJ. Androgenetic alopecia in the paediatric population: A retrospective review of 57 patients. Br J Dermatol 2010;163(2):378-85
    • (2010) Br J Dermatol , vol.163 , Issue.2 , pp. 378-385
    • Gonzalez, M.E.1    Cantatore-Francis, J.2    Orlow, S.J.3
  • 52
    • 84860346016 scopus 로고    scopus 로고
    • British Association of Dermatologists' guidelines for the management of alopecia areata 2012
    • Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012;166(5):916-26
    • (2012) Br J Dermatol , vol.166 , Issue.5 , pp. 916-926
    • Messenger, A.G.1    McKillop, J.2    Farrant, P.3
  • 53
    • 84861371950 scopus 로고    scopus 로고
    • Alopecia areata: A new treatment plan
    • Alsantali A. Alopecia areata: A new treatment plan. Clin Cosmet Investig Dermatol 2011;4:107-15
    • (2011) Clin Cosmet Investig Dermatol , vol.4 , pp. 107-115
    • Alsantali, A.1
  • 54
    • 0037710129 scopus 로고    scopus 로고
    • Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
    • Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49(1):96-8
    • (2003) J Am Acad Dermatol , vol.49 , Issue.1 , pp. 96-98
    • Tosti, A.1    Piraccini, B.M.2    Pazzaglia, M.3    Vincenzi, C.4
  • 55
    • 33750300542 scopus 로고    scopus 로고
    • Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial
    • Tosti A, Iorizzo M, Botta GL, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 2006;20(10):1243-7
    • (2006) J Eur Acad Dermatol Venereol , vol.20 , Issue.10 , pp. 1243-1247
    • Tosti, A.1    Iorizzo, M.2    Botta, G.L.3    Milani, M.4
  • 56
    • 34948821188 scopus 로고    scopus 로고
    • Pulse corticosteroid therapy for alopecia areata: Study of 139 patients
    • Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology 2007;215(4):320-4
    • (2007) Dermatology , vol.215 , Issue.4 , pp. 320-324
    • Nakajima, T.1    Inui, S.2    Itami, S.3
  • 57
    • 42049107760 scopus 로고    scopus 로고
    • Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy
    • Hubiche T, Leaute-Labreze C, Taeb A, Boralevi F. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008;158(5):1136-7
    • (2008) Br J Dermatol , vol.158 , Issue.5 , pp. 1136-1137
    • Hubiche, T.1    Leaute-Labreze, C.2    Täeb, A.3    Boralevi, F.4
  • 58
    • 0031710804 scopus 로고    scopus 로고
    • Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients
    • Friedli A, Labarthe MP, Engelhardt E, et al. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998;39(4Pt 1):597-602
    • (1998) J Am Acad Dermatol , vol.39 , Issue.4 , pp. 597-602
    • Friedli, A.1    Labarthe, M.P.2    Engelhardt, E.3
  • 59
    • 0030045892 scopus 로고    scopus 로고
    • Pulsed administration of corticosteroids in the treatment of alopecia areata
    • Sharma VK. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996;35(2):133-6
    • (1996) Int J Dermatol , vol.35 , Issue.2 , pp. 133-136
    • Sharma, V.K.1
  • 60
    • 0032881006 scopus 로고    scopus 로고
    • Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata
    • Sharma VK, Gupta S. Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata. J Dermatol 1999;26(9):562-5
    • (1999) J Dermatol , vol.26 , Issue.9 , pp. 562-565
    • Sharma, V.K.1    Gupta, S.2
  • 62
    • 73649139228 scopus 로고    scopus 로고
    • Alopecia areata update: Part II,treatment
    • Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010;62(2):191-202
    • (2010) J Am Acad Dermatol , vol.62 , Issue.2 , pp. 191-202
    • Alkhalifah, A.1    Alsantali, A.2    Wang, E.3
  • 63
    • 0031742416 scopus 로고    scopus 로고
    • Efficacy of topical sensitizers in the treatment of alopecia areata
    • Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998;39(5Pt1):751-61
    • (1998) J Am Acad Dermatol , vol.39 , Issue.5 , pp. 751-761
    • Rokhsar, C.K.1    Shupack, J.L.2    Vafai, J.J.3    Washenik, K.4
  • 64
    • 0026082648 scopus 로고
    • Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone
    • Van der Steen PH, van Baar HM, Happle R, et al. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991;24(2Pt1):227-30
    • (1991) J Am Acad Dermatol , vol.24 , Issue.2 , pp. 227-230
    • Van Der Steen, P.H.1    Van Baar, H.M.2    Happle, R.3
  • 65
    • 0025742887 scopus 로고
    • Alopecia areata in children: Response to treatment with diphencyprone
    • MacDonald Hull S, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 1991;125(2):164-8
    • (1991) Br J Dermatol , vol.125 , Issue.2 , pp. 164-168
    • MacDonald Hull, S.1    Pepall, L.2    Cunliffe, W.J.3
  • 66
    • 0029743894 scopus 로고    scopus 로고
    • Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis
    • Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996;35(2Pt1):199-201
    • (1996) J Am Acad Dermatol , vol.35 , Issue.2 , pp. 199-201
    • Tosti, A.1    Guidetti, M.S.2    Bardazzi, F.3    Misciali, C.4
  • 68
    • 0029620668 scopus 로고
    • PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years' experience at st john's institute of dermatology
    • Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 1995;133(60):914-18
    • (1995) Br J Dermatol , vol.133 , Issue.60 , pp. 914-918
    • Taylor, C.R.1    Hawk, J.L.2
  • 69
    • 0027184062 scopus 로고
    • PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases
    • Healy E, Rogers S. PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases. Br J Dermatol 1993;129(1):42-4
    • (1993) Br J Dermatol , vol.129 , Issue.1 , pp. 42-44
    • Healy, E.1    Rogers, S.2
  • 70
    • 84907227637 scopus 로고    scopus 로고
    • Excimer laser: A module of the alopecia areata common protocol
    • McMichael AJ. Excimer laser: A module of the alopecia areata common protocol. J Invest Dermatol Symp Proc 2013;16(1):S77-9
    • (2013) J Invest Dermatol Symp Proc , vol.16 , Issue.1 , pp. S77-S79
    • McMichael, A.J.1
  • 71
    • 70350023131 scopus 로고    scopus 로고
    • 308-nm excimer laser for the treatment of alopecia areata in children
    • Al Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 2009;26(5):547-50
    • (2009) Pediatr Dermatol , vol.26 , Issue.5 , pp. 547-550
    • Al Mutairi, N.1
  • 72
    • 84922496418 scopus 로고    scopus 로고
    • Treatment of alopecia areata with simvastatin/ezetimibe
    • Lattouf C, Jimenez JJ, Tosti A, et al. Treatment of alopecia areata with simvastatin/ezetimibe. J Am Acad Dermatol 2015;72(2):359-61
    • (2015) J Am Acad Dermatol , vol.72 , Issue.2 , pp. 359-361
    • Lattouf, C.1    Jimenez, J.J.2    Tosti, A.3
  • 73
    • 84908315856 scopus 로고    scopus 로고
    • Alopecia areata is driven by cytotoxic lymphocytes and is reversed by JAK inhibition
    • Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic lymphocytes and is reversed by JAK inhibition. Nat Med 2014;20(9):1043-9
    • (2014) Nat Med , vol.20 , Issue.9 , pp. 1043-1049
    • Xing, L.1    Dai, Z.2    Jabbari, A.3
  • 74
    • 84904130542 scopus 로고    scopus 로고
    • Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata
    • Castela E, Le Duff F, Butori C, et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata. JAMA Dermatol 2014;150(7):748-51
    • (2014) JAMA Dermatol , vol.150 , Issue.7 , pp. 748-751
    • Castela, E.1    Le Duff, F.2    Butori, C.3
  • 75
    • 84883420789 scopus 로고    scopus 로고
    • A randomized, double-blind, placeboand active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata
    • Trink A, Sorbellini E, Bezzola P, et al. A randomized, double-blind, placeboand active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol 2013;169(3):690-4
    • (2013) Br J Dermatol , vol.169 , Issue.3 , pp. 690-694
    • Trink, A.1    Sorbellini, E.2    Bezzola, P.3
  • 76
    • 45749158921 scopus 로고    scopus 로고
    • Management of primary cicatricial alopecias: Options for treatment
    • Harries Mj, Sinclair RD, MacDonald-Hull S, et al. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol 2008;159(1):1-22
    • (2008) Br J Dermatol , vol.159 , Issue.1 , pp. 1-22
    • Harries, M.J.1    Sinclair, R.D.2    MacDonald-Hull, S.3
  • 77
    • 84908887283 scopus 로고    scopus 로고
    • Red face revisited: Disorders of hair growth and the pilosebaceous unit
    • Ramos-e-Silva M, Pirmez R. Red face revisited: Disorders of hair growth and the pilosebaceous unit. Clin Dermatol 2014;32:784-99
    • (2014) Clin Dermatol , vol.32 , pp. 784-799
    • Ramos-e-Silva, M.1    Pirmez, R.2
  • 78
    • 84895812536 scopus 로고    scopus 로고
    • Lichen planopilaris: Epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients
    • Meinhard J, Stroux A, Lünnemann L, et al. Lichen planopilaris: Epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients. J Dtsch Dermatol Ges 2014;12(3):229-35
    • (2014) J Dtsch Dermatol Ges , vol.12 , Issue.3 , pp. 229-235
    • Meinhard, J.1    Stroux, A.2    Lünnemann, L.3
  • 79
    • 0347003662 scopus 로고    scopus 로고
    • Primary cicatricial alopecias: Clinicopathology of 112 cases
    • Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004;50(1):25-32
    • (2004) J Am Acad Dermatol , vol.50 , Issue.1 , pp. 25-32
    • Tan, E.1    Martinka, M.2    Ball, N.3    Shapiro, J.4
  • 81
    • 63049089516 scopus 로고    scopus 로고
    • Lichen planopilaris: Update on diagnosis and treatment
    • Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009;28(1):3-10
    • (2009) Semin Cutan Med Surg , vol.28 , Issue.1 , pp. 3-10
    • Assouly, P.1    Reygagne, P.2
  • 82
    • 84922575303 scopus 로고    scopus 로고
    • The use of oral pioglitazone in the treatment of lichen planopilaris
    • Mesinkovska NA, Tellez A, Dawes D, et al. The use of oral pioglitazone in the treatment of lichen planopilaris. J Am Acad Dermatol 2015;72(2):355-6
    • (2015) J Am Acad Dermatol , vol.72 , Issue.2 , pp. 355-356
    • Mesinkovska, N.A.1    Tellez, A.2    Dawes, D.3
  • 83
    • 0033373872 scopus 로고    scopus 로고
    • Low molecular weight heparin: A novel alternative therapeutic approach for lichen planus
    • Stefanidou MP, Ioannidou DJ, Panayiotides JG, Tosca AD. Low molecular weight heparin: A novel alternative therapeutic approach for lichen planus. Br J Dermatol 1999;141:1040-5
    • (1999) Br J Dermatol , vol.141 , pp. 1040-1045
    • Stefanidou, M.P.1    Ioannidou, D.J.2    Panayiotides, J.G.3    Tosca, A.D.4
  • 84
    • 81855168388 scopus 로고    scopus 로고
    • Low-dose excimer 308-nm laser for treatment of lichen planopilaris
    • Navarini A, Kolios AG, Prinz-Vavricka BM, et al. Low-dose excimer 308-nm laser for treatment of lichen planopilaris. Arch Dermatol 2011;147(11):1325-6
    • (2011) Arch Dermatol , vol.147 , Issue.11 , pp. 1325-1326
    • Navarini, A.1    Kolios, A.G.2    Prinz-Vavricka, B.M.3
  • 86
    • 84896097645 scopus 로고    scopus 로고
    • Frontal fibrosing alopecia: A multicentre review of 355 patients
    • Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al. Frontal fibrosing alopecia: A multicentre review of 355 patients. J Am Acad Dermatol 2014;70(4):670-8
    • (2014) J Am Acad Dermatol , vol.70 , Issue.4 , pp. 670-678
    • Vano-Galvan, S.1    Molina-Ruiz, A.M.2    Serrano-Falcon, C.3
  • 87
    • 33644873943 scopus 로고    scopus 로고
    • Female pattern hair loss and its relationship to permanent/cicatricial alopecia: A new perspective
    • Olsen EA. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: A new perspective. J Investig Dermatol Symp Proc 2005;10(3):217-21
    • (2005) J Investig Dermatol Symp Proc , vol.10 , Issue.3 , pp. 217-221
    • Olsen, E.A.1
  • 91
    • 80052969201 scopus 로고    scopus 로고
    • Innate immunity: A crucial target for zinc in the treatment of inflammatory dermatosis
    • Brocard A, Dreno B. Innate immunity: A crucial target for zinc in the treatment of inflammatory dermatosis. J Eur Acad Dermatol Venereol 2011;25(10):1146-52
    • (2011) J Eur Acad Dermatol Venereol , vol.25 , Issue.10 , pp. 1146-1152
    • Brocard, A.1    Dreno, B.2
  • 92
    • 84890396155 scopus 로고    scopus 로고
    • Long-term remission of folliculitis decalvans after treatment with the long-pulsed Nd:YAG laser
    • Meesters AA, Van der Veen JP, Wolkerstorfer A. Long-term remission of folliculitis decalvans after treatment with the long-pulsed Nd:YAG laser. J Dermatol Treat 2014;25(2):167-8
    • (2014) J Dermatol Treat , vol.25 , Issue.2 , pp. 167-168
    • Meesters, A.A.1    Van Der Veen, J.P.2    Wolkerstorfer, A.3
  • 93
    • 84901189715 scopus 로고    scopus 로고
    • Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): A comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa
    • Scheinfeld N. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): A comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa. Dermatol Online J 2014;20(5):22692
    • (2014) Dermatol Online J , vol.20 , Issue.5 , pp. 22692
    • Scheinfeld, N.1
  • 94
    • 84922282428 scopus 로고    scopus 로고
    • Dissecting cellulitis of the scalp: A retrospective study of 7 cases confirming the efficacy of oral isotretinoin
    • Koudoukpo C, Abdennader S, Cavelier-Balloy B, et al. Dissecting cellulitis of the scalp: A retrospective study of 7 cases confirming the efficacy of oral isotretinoin. Ann Dermatol Venereol 2014;14(8-9):500-6
    • (2014) Ann Dermatol Venereol , vol.14 , Issue.8-9 , pp. 500-506
    • Koudoukpo, C.1    Abdennader, S.2    Cavelier-Balloy, B.3
  • 95
    • 84861366665 scopus 로고    scopus 로고
    • Treatment options for alopecia: An update, looking to the future
    • Miteva M, Tosti A. Treatment options for alopecia: An update, looking to the future. Expert Opin Pharmacother 2012;13(9):1271-81
    • (2012) Expert Opin Pharmacother , vol.13 , Issue.9 , pp. 1271-1281
    • Miteva, M.1    Tosti, A.2
  • 97
    • 84863344412 scopus 로고    scopus 로고
    • Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia
    • Garza LA, Liu Y, Yang Z, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med 2012;4(126):126ra34
    • (2012) Sci Transl Med , vol.4 , Issue.126 , pp. 126-134
    • Garza, L.A.1    Liu, Y.2    Yang, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.